Material Type

• Blood (whole) (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Other (2)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (1)
• Serum (1)
• Solid tissue (non viable) (1)
• Stool (1)
• Urine (random) (3)

Microscopic Assessment

• Affected (6)
• Non-affected (1)
• Not applicable (1)

Storage Temperature

• RT (3)
• -35°C to -18°C (1)
• -85°C to -60°C (4)

Associated Data

• Clinical records (4)
• Followup records (2)
• Freezer temperature logs (3)
• Microbiological results (1)
• Participant Ethnicity (2)
• Physiological/biochemical measurements (1)
• Pre-analytical data (1)
• Survey data (2)
• Treatment records (2)

Timeframe

• Immediate (3)
• 0 - 3 months (4)
• 3 - 6 months (2)
• > 6 months (2)

Participant Count

• 11 - 100 (3)
• 101 - 500 (4)

Sex

• Female (1)
• Both sexes (6)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (2)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (5)
• Adult (> 40 years) (3)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Digital imaging (1)
• Infectious strain isolation (1)
• Molecular Extractions (1)
• Nucleic acid extraction (2)

Collection Type

• Case-control (1)
• Clinical Trial (1)
• Cohort (1)
• Cross-sectional (1)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (5)
• No Export restriction (6)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (5)
• No Scope of use restriction (4)

Collection Status

• Completed (3)
• In progress (3)

Access Condition

• Open in response to specific calls (1)
• Open only through collaboration (4)
• Access restricted at present (1)

Country

• Democratic Republic of the Congo (1)
• Ghana (1)
• Peru (1)
• Spain (1)
• Switzerland (1)
• Uganda (1)

County